Search

"The Challenge of New Psychoactive Substances – A Technical Update 2024" is an update of the UNODC publication “The Challenge of New Psychoactive Substances (NPS), 2013”, which focuses on the new psychoactive substances (NPS) encountered on...

The report summarises the evidence drawn from worldwide evidence reviews, mathematical modelling, and extensive consultations and discussions. The Guidance provides people in Canada with accurate and current information about the risk of...

The report, "Clearing the Smoke on Cannabis: Medical Use of Cannabis and Cannabinoids 2024 Update," examines the medical use of cannabis and cannabinoids, emphasizing their effects, efficacy, and the need for more rigorous research. Key...

Introduction: As people increasingly migrate to online shopping platforms, hard-won improvements in requirements for consumer information provision at the point of sale are being eroded. An example is the alcohol pregnancy warning label for...

Specific patterns of substance use have been found to correlate with an elevated risk of suicidal thoughts, attempts, and mortality by suicide. However, this relationship is multifaceted and influenced by various intersecting factors...

We are thrilled to share the first-ever Global Position Paper on Recovery (GPPR), developed by WFAD's Recovered Users Network (RUN) and the Global Recovery Task Force. The document unites recovery organisations [and beyond], institutions...

The Vienna & New York NGO Committees on Drugs are pleased to present the global civil society report for the 2024 mid-term review of the Commission on Narcotic Drugs (CND).
The report is the result of constructive inputs by more than 200...

The Cannabis, Mental Health, and Substance Use Health: Research Knowledge Exchange Event Summary Report presents the findings and themes discussed at an event jointly hosted by CCSA (Canadian Centre on Substance Use and Addiction) and the...

SAMHSA report discusses the evidence supporting the effectiveness of screening, brief intervention, and referral to treatment (SBIRT) as a comprehensive approach, as well as for the implementation and effectiveness of the individual...

The DIMS annual report 2022 covers the concentrations, adulterations, and other relevant information produced by DIMS in the past year, and in doing so forms a topical image of the Dutch drug market. Spread out over all Dutch provinces, the...

Harm reduction (HR) has been a pillar of drug policy in the Netherlands for many decades. In fact, the Netherlands was a pioneer in the field of HR. Like many other Western countries, the Netherlands was hit by a wave of heroin use in the...

While integrated services for mental health and substance use health have been studied for more than two decades no recent or comprehen­sive reviews exist — particularly with a peer research methodology — on how the people who use these...